We are live on ! Find out more
SRDX

Surmodics
SRDX

Delisted

SRDX was delisted on the 18th of November, 2025.

Back to rankings

103 hedge funds and large institutions have $395M invested in Surmodics in 2023 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 34 increasing their positions, 34 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

2% more capital invested

Capital invested by funds: $385M → $395M (+$9.61M)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 34

0.1% less ownership

Funds ownership: 87.07% → 86.97% (-0.1%)

2% less funds holding

Funds holding: 105 → 103 (-2)

17% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 12

96% less call options, than puts

Call options by funds: $13K | Put options by funds: $340K

Holders
103
Holders Change
-2
Holders Change %
-1.9%
% of All Funds
1.63%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
10
Increased
34
Reduced
34
Closed
12
Calls
$13K
Puts
$340K
Net Calls
-$327K
Net Calls Change
+$1.68M

Top Buyers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
+$6.87M
2
DGI
Disciplined Growth Investors
Minnesota
+$6.41M
3
Morgan Stanley
Morgan Stanley
New York
+$2.12M
4
GIP
Granite Investment Partners
California
+$2.11M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$1.9M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$10.5M
2
SCM
Soleus Capital Management
Connecticut
-$3.6M
3
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$2.56M
4
KCM
Kennedy Capital Management
Missouri
-$2.16M
5
Citadel Advisors
Citadel Advisors
Florida
-$2.07M

SRDX Hedge Fund Activity: Q3 2023 in Review

103 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Surmodics (SRDX) for Q3 2023, worth a combined $395M — up 2.5% from $385M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of SRDX and 10 opened new positions — a net loss of 2 holders — while 34 trimmed existing stakes and 34 added.

The largest buyer was Bank of America, adding an estimated $6.87M. The largest seller was Millennium Management, cutting an estimated $10.5M.

  • 103 institutional investors held Surmodics (SRDX) as of Q3 2023, down from 105 in Q2 2023.
  • Funds reported $395M of Surmodics stock for Q3 2023, up 2.5% quarter-over-quarter.
  • 10 funds opened new Surmodics positions in Q3 2023 and 12 closed out, a net change of -2 holders.
  • The largest Surmodics buyer in Q3 2023 was Bank of America, an estimated $6.87M added.
  • The largest Surmodics seller in Q3 2023 was Millennium Management, an estimated $10.5M sold.

Based on aggregated 13F filings for Q3 2023.